期刊文献+

多药耐药性P-糖蛋白在药物肠道吸收中的作用 被引量:23

Key role of the multidrug resistance P-glycoprotein in the intestinal absorption of drugs
下载PDF
导出
摘要 目的综述近五年来多药耐药性P 糖蛋白作用于药物肠道吸收过程的研究进展。方法在查阅文献的基础上介绍了P 糖蛋白的分子结构、作用机制及其底物、抑制剂和诱导剂 ,并阐明P 糖蛋白对药物肠道吸收的作用及其所引起的临床上药物相互作用。结果与结论P 糖蛋白积极参与药物肠道吸收过程 ,充分了解这一点有助于合理设计药物制剂处方 ,提高药物生物利用度 。 Objective To review the development of the key role of P-glycoprotein (P-gp) in the intestinal absorption of drugs during the past five years.Methods The molecule structure,action mechanism and sustrates,inhibitors or inducers of P-gp were introduced.The key role of P-gp in the intestinal absorption of drugs was illuminated.Results and Conclusions P-glycoprotein plays a key role in the intestinal absorption of drugs.
出处 《沈阳药科大学学报》 CAS CSCD 2004年第5期389-393,共5页 Journal of Shenyang Pharmaceutical University
关键词 P-糖蛋白 药物肠道吸收 药物相互作用 CYP3A4 制剂辅料 P-glycoprotein intestinal absorption drug interaction CYP3A4 pharmaceutical excipients
  • 相关文献

参考文献22

  • 1[1]Barrand MA,Bagrij T,Neo SY.Multidrug resistanceassociated protein:a protein distinct from P-glycoprotein involved in cytotoxic drug expulsion [J].Gen Pharmac,1997,28:629-651.
  • 2[2]Loo T,Clarke DJ.The transmembrane domains of the human multidrug resistance P-glycoprotein are sufficient to mediate drug binding and trafficking to the cell surface [J].Biol Chem,1999,274:24759-24765.
  • 3[3]Kramer R,Weber TK,Arceci R.Inhibition of N-linked glycosylation of P-glycoproptein by tunicamycin results in a reduced multidrug resistance phenotype [J].Br J Cancer,1995,71:760-676.
  • 4[4]Higgins CF.ABC transporters:from microorganisms to man[J].Ann Rev Cell Biol,1992,8:76-113.
  • 5[5]Cornwell MM,Safa AR,Felsted RL,et al.Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150- to 170- kua protein detected by photoaffinity labeling [J].Proc Natl Acad Sci USA,1986,83:3847-3850.
  • 6[6]Akiyama SI,Cornwell MM,Kuwano M,et al.Most drugs that reverse multidrug resistance also inhibitphotoaffinity labeling of P-glycoprotein by a vinblastine analog [J].Mol Pharmacol,1988,33:144-147.
  • 7[7]Richard B Kin.Drugs as P-glycoprotein substrates,inhibitors,and inducers [J].Drug Metab Rev,2002,34(1-2):47-54.
  • 8[8]Seelig A.A general pattern for substrate recognition by P-glycoprotein [J].Eur J Biochem,1998,251:252-261.
  • 9[9]Kim RB,Fromm MF,Wandel C,et al.The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors [J].J Clin Invest,1998,10:289-294.
  • 10[10]Sun J,Sakai S,Tauchi Y,et al.Determination of lipophilicity of two quinolone antibacterials,ciprofloxacin and grepafloxacin,in the protonation equilibrium [J].Eur J Pharm Biopharm,2002,54(1):51-58.

同被引文献256

引证文献23

二级引证文献120

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部